← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2015Last known activity
Dec 11, 2025
Acquired by Indevus Pharmaceuticals → Endo Pharmaceuticals → Mallinckrodt (2013) on Jan 1, 2006
Timeline
2000s
- Jan 1, 2006
Indevus Pharmaceuticals— Acquired By
2010s
- Jun 1, 2010
Moderna Therapeutics— Founded
2020s
- Mar 1, 2025
Mallinckrodt (2013)— Now
Drugs by trial phase (68 distinct, 104 trials)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Amino Acid Metabolism, Inborn Errors
- Chikungunya Fever
- Cytomegalovirus Infections
- Infections
- Influenza, Human
- Lymphoma
- Melanoma
- Metabolism, Inborn Errors
- Neoplasms
- Paramyxoviridae Infections
- Propionic Acidemia
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
- Virus Diseases
- Zika Virus Infection
Recent trials (50)
- NCT07279766CollaboratorPhase 4Dec 11, 2025
- NCT07221474CollaboratorPhase 2Dec 2, 2025
- NCT07116616Lead sponsorPhase 1/Phase 2Sep 30, 2025
- NCT07117487Lead sponsorPhase 3Aug 5, 2025
- NCT06946225CollaboratorPhase 1Jul 25, 2025
- NCT07089706Lead sponsorPhase 4Jul 21, 2025
- NCT06880549Lead sponsorPhase 1Mar 25, 2025
- NCT06833073CollaboratorPhase 2Mar 17, 2025
- NCT06864143Lead sponsorPhase 2Mar 7, 2025
- NCT06694753CollaboratorPhase 1Feb 19, 2025
- NCT06735248Lead sponsorPhase 2Dec 31, 2024
- NCT06655870Lead sponsorPhase 1Oct 29, 2024
- NCT06623422CollaboratorPhase 3Oct 21, 2024
- NCT06634797Lead sponsorPhase 4Oct 8, 2024
- NCT06592794Lead sponsorPhase 3Sep 24, 2024
Details
- Founded
- Cambridge, MA, US Jun 1, 2010
- Last known activity
- Dec 11, 2025